Status:
UNKNOWN
Asymptomatic Inflammatory Bowel Disease in Catalonia
Lead Sponsor:
Corporacion Parc Tauli
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Brief Summary
An early treatment of inflammatory bowel disease (IBD) has been proposed to correlate to better outcomes. In Catalonia the screening programme was implemented in all the territory in 2015. The aim of ...
Detailed Description
This study will be performed and reported according to the STROBE Statement guidelines ( http://www.strobe-statement.org/index.php?id=strobe-home). Design: Observational, multicentre and retrospecti...
Eligibility Criteria
Inclusion
- All patients with asymptomatic IBD diagnosed during the population colorectal cancer screening in the Catalonian colorectal screening program within the period 2000 to 2019 will be included.
Exclusion
- Symptoms in the first outpatient visit.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04794465
Start Date
April 1 2021
End Date
October 31 2021
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corporació Sanitària Parc Taulí
Sabadell, Barcelona, Spain, 08208